世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

低分子ヘパリンの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2022-2028年


Global Low Molecular Weight Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

低分子ヘパリン(LMWH)は、UFH(未分画ヘパリン)から、化学分解、酵素分解、ガンマ線切断などの過程を経て製造されます。 天然のヘパリンは、様々な長さの分子鎖、すなわち分子量から構成されています。5000ダ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年9月5日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

低分子ヘパリン(LMWH)は、UFH(未分画ヘパリン)から、化学分解、酵素分解、ガンマ線切断などの過程を経て製造されます。
天然のヘパリンは、様々な長さの分子鎖、すなわち分子量から構成されています。5000ダルトンから4万ダルトン以上の様々な分子量の鎖が、多分散性の医薬品グレードのヘパリンを構成しています。これに対して、LMWHは、短い多糖類の鎖のみから構成されている。LMWHは、平均分子量が8000 Da未満で、全鎖の少なくとも60%が8000 Da未満の分子量を持つヘパリン塩と定義される。

ハイライト
COVID-19やロシア・ウクライナ戦争の影響による経済変化を考慮すると、低分子ヘパリンの世界市場は、2023年から2028年の間にCAGR5.4%で、2022年の推定3億5840万米ドルから2028年までに4億9140万米ドルに達すると予測されます。
世界の低分子ヘパリン主要企業は、Aspen、Sanofi-aventis、CSBIO、Dongying Tiandong Pharmaceutical、Techdowなどです。上位5社で55%以上のシェアを占めています。欧州が最大市場であり、シェアは約35%。

レポート範囲
本レポートは、低分子ヘパリンの世界市場について定量的・定性的な分析を行い、読者がビジネス/成長戦略の策定、市場競争状況の評価、現在の市場における自社のポジション分析、および低分子ヘパリンに関するビジネス上の意思決定を行うために役立つ情報を包括的に提供することを目的としています。
低分子ヘパリンの市場規模、推計、予測は、2021年を基準年とし、2017年から2028年までの歴史と予測データを考慮して、販売量(MT)および収益(百万ドル)で提供しています。本レポートでは、世界の低分子量ヘパリン市場を包括的にセグメント化しています。また、タイプ別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。市場規模を推定する際には、COVID-19とロシア・ウクライナ戦争の影響を考慮しました。
市場をより深く理解するために、競合環境、主要な競合他社のプロファイル、それぞれの市場ランクを提供しています。また、技術動向や新製品開発についても考察しています。
当レポートは、低分子量ヘパリンメーカー、新規参入企業、産業チェーン関連企業に対して、市場全体およびサブセグメントにおける企業別、製品タイプ別、用途別、地域別の収益、販売量、平均価格に関する情報を提供し、同市場の発展に貢献するものである。

主要企業および市場シェアの洞察
本セクションでは、読者は競合する主要企業について理解を深めることができます。本レポートでは、革新的なトレンドと開発、製品ポートフォリオの強化、M&A、コラボレーション、新製品イノベーション、地域的拡大など、これらの参加企業がプレゼンスを維持するために行った主要な成長戦略を調査しています。事業戦略とは別に、本調査には現在の開発状況や主要財務情報も含まれています。読者はまた、期間2017-2022のメーカー別の世界収益、価格、売上高に関連するデータにアクセスすることができます。この包括的なレポートは、確かに更新を維持し、彼らのビジネスで効果的な意思決定を行うためにクライアントに役立つだろう。調査レポートでレビューされている著名なプレーヤーは以下の通りです。
アスペン
サノフィ-アベンティス
ファイザー
オポクリン
CSBIO
東営天東製薬
常州乾宏生物製薬
テクダウ
烟台東城製薬集団

製品タイプ別インサイト
世界市場を低分子ヘパリンのタイプ別に、2028年までの成長予測とともに紹介します。売上高と収益に関する推定は、低分子ヘパリンがメーカーから調達されるサプライチェーンにおける価格に基づいています。
本レポートでは、各セグメントを調査し、過去のデータを用いて市場規模を提示しています。また、そのセグメントが将来もたらすかもしれない成長機会についても触れています。この研究は、タイプ別、および歴史的期間(2017-2022)と予測期間(2023-2028)の売上と収益のデータを授けるものです。
低分子ヘパリン タイプ別セグメント
エノキサパリン
ダルテパリン
ティンザパリン
フラキシパリン

アプリケーションインサイト
本レポートでは、過去期間(2017-2022年)および予測期間(2023-2028年)における、アプリケーション別の市場規模(売上高および収益データ)を掲載しています。
また、低分子ヘパリン市場に影響を与える各分野の市場動向や消費者行動について概説し、これらが業界の将来にどのような示唆を与えるかについて解説しています。本レポートは、低分子ヘパリン市場を牽引する関連市場および消費者動向の把握にお役立ていただけます。
低分子ヘパリンの用途別セグメント
静脈血栓塞栓症の治療
妊娠の合併症
心房細動/粗動の除細動
その他

地域別の展望
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際には、経済的、社会的、環境的、技術的、政治的要因が考慮されています。読者はまた、2017年から2028年までの各地域と国の収益と売上データを手にすることができます。
市場は、北米、ヨーロッパ、アジア太平洋、南米、中東&アフリカなど、さまざまな主要地域に区分されています。アメリカ、ドイツ、イギリス、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされる予定です。市場推定については、2021年を基準年としてデータを提供し、2022年の推定値と2028年の予測収益を提供する予定である。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
ベネルクス
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
中南米
メキシコ
ブラジル
アルゼンチン
ラテンアメリカのその他
中近東・アフリカ
トルコ
サウジアラビア
UAE
その他の中東・アフリカ

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、低分子量ヘパリン市場のシナリオがパンデミック、ポストパンデミック、ロシア・ウクライナ戦争中に世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面の変化を視野に入れて行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要な要因を取り上げています。

本レポートを購入する理由
本レポートは、読者が産業内の競争と、潜在的な利益を高めるための競争環境に対する戦略を理解するのに役立ちます。また、世界の低分子ヘパリン市場の競争環境に焦点を当て、主要企業の市場シェア、産業ランキング、競合他社のエコシステム、市場実績、新製品開発、経営状況、拡張、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解できるよう支援します。
本レポートは、関係者が低分子量ヘパリンの世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をより良く理解し、ビジネスにおける地位を強化するためのより多くの洞察を得るために役立ちます。競争環境のセクションでは、市場シェアと順位(数量と金額)、競合のエコシステム、新製品開発、拡大、買収を含みます。
本レポートは、新規技術の統合、機能、市場の最新動向について常に更新しています。
本レポートは、関係者がCOVID-19とロシア・ウクライナ戦争が低分子量ヘパリン産業に及ぼす影響を理解するのに役立ちます。
本レポートは、関係者が世界的にどの地域をターゲットとすべきなのかについての洞察を得るのに役立ちます。
本レポートは、利害関係者が低分子ヘパリンの採用に関するエンドユーザーの認識について洞察するのに役立ちます。
本レポートは、利害関係者が市場における主要プレイヤーを特定し、その貴重な貢献度を理解するのに役立ちます。


ページTOPに戻る


目次

1 Study Coverage
1.1 Low Molecular Weight Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Low Molecular Weight Heparin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Market by Application
1.3.1 Global Low Molecular Weight Heparin Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Low Molecular Weight Heparin Market Size Estimates and Forecasts
2.1.1 Global Low Molecular Weight Heparin Revenue 2017-2028
2.1.2 Global Low Molecular Weight Heparin Sales 2017-2028
2.2 Low Molecular Weight Heparin Market Size by Region: 2022 Versus 2028
2.3 Low Molecular Weight Heparin Sales by Region (2017-2028)
2.3.1 Global Low Molecular Weight Heparin Sales by Region: 2017-2022
2.3.2 Global Low Molecular Weight Heparin Sales Forecast by Region (2023-2028)
2.3.3 Global Low Molecular Weight Heparin Sales Market Share by Region (2017-2028)
2.4 Low Molecular Weight Heparin Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Low Molecular Weight Heparin Revenue by Region: 2017-2022
2.4.2 Global Low Molecular Weight Heparin Revenue Forecast by Region (2023-2028)
2.4.3 Global Low Molecular Weight Heparin Revenue Market Share by Region (2017-2028)
3 Global Low Molecular Weight Heparin by Manufacturers
3.1 Global Top Low Molecular Weight Heparin Manufacturers by Sales
3.1.1 Global Low Molecular Weight Heparin Sales by Manufacturer (2017-2022)
3.1.2 Global Low Molecular Weight Heparin Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Low Molecular Weight Heparin Manufacturers by Revenue
3.2.1 Global Low Molecular Weight Heparin Revenue by Manufacturer (2017-2022)
3.2.2 Global Low Molecular Weight Heparin Revenue Share by Manufacturer (2017-2022)
3.3 Global Low Molecular Weight Heparin Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Low Molecular Weight Heparin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Low Molecular Weight Heparin Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Low Molecular Weight Heparin Manufacturing Base Distribution, Product Type
3.5.1 Low Molecular Weight Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Low Molecular Weight Heparin Product Type
3.5.3 Date of International Manufacturers Enter into Low Molecular Weight Heparin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Aspen
4.1.1 Aspen Corporation Information
4.1.2 Aspen Description, Business Overview
4.1.3 Aspen Low Molecular Weight Heparin Products Offered
4.1.4 Aspen Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Aspen Low Molecular Weight Heparin Sales by Product in 2021
4.1.6 Aspen Low Molecular Weight Heparin Sales by Application in 2021
4.1.7 Aspen Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.1.8 Aspen Recent Developments
4.2 Sanofi-aventis
4.2.1 Sanofi-aventis Corporation Information
4.2.2 Sanofi-aventis Description, Business Overview
4.2.3 Sanofi-aventis Low Molecular Weight Heparin Products Offered
4.2.4 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Sanofi-aventis Low Molecular Weight Heparin Sales by Product in 2021
4.2.6 Sanofi-aventis Low Molecular Weight Heparin Sales by Application in 2021
4.2.7 Sanofi-aventis Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.2.8 Sanofi-aventis Recent Developments
4.3 Pfizer
4.3.1 Pfizer Corporation Information
4.3.2 Pfizer Description, Business Overview
4.3.3 Pfizer Low Molecular Weight Heparin Products Offered
4.3.4 Pfizer Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Pfizer Low Molecular Weight Heparin Sales by Product in 2021
4.3.6 Pfizer Low Molecular Weight Heparin Sales by Application in 2021
4.3.7 Pfizer Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.3.8 Pfizer Recent Developments
4.4 Opocrin
4.4.1 Opocrin Corporation Information
4.4.2 Opocrin Description, Business Overview
4.4.3 Opocrin Low Molecular Weight Heparin Products Offered
4.4.4 Opocrin Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Opocrin Low Molecular Weight Heparin Sales by Product in 2021
4.4.6 Opocrin Low Molecular Weight Heparin Sales by Application in 2021
4.4.7 Opocrin Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.4.8 Opocrin Recent Developments
4.5 CSBIO
4.5.1 CSBIO Corporation Information
4.5.2 CSBIO Description, Business Overview
4.5.3 CSBIO Low Molecular Weight Heparin Products Offered
4.5.4 CSBIO Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.5.5 CSBIO Low Molecular Weight Heparin Sales by Product in 2021
4.5.6 CSBIO Low Molecular Weight Heparin Sales by Application in 2021
4.5.7 CSBIO Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.5.8 CSBIO Recent Developments
4.6 Dongying Tiandong Pharmaceutical
4.6.1 Dongying Tiandong Pharmaceutical Corporation Information
4.6.2 Dongying Tiandong Pharmaceutical Description, Business Overview
4.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Products Offered
4.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales by Product in 2021
4.6.6 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales by Application in 2021
4.6.7 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.6.8 Dongying Tiandong Pharmaceutical Recent Development
4.7 Changzhou Qianhong Bio-pharma
4.7.1 Changzhou Qianhong Bio-pharma Corporation Information
4.7.2 Changzhou Qianhong Bio-pharma Description, Business Overview
4.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Products Offered
4.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales by Product in 2021
4.7.6 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales by Application in 2021
4.7.7 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.7.8 Changzhou Qianhong Bio-pharma Recent Development
4.8 Techdow
4.8.1 Techdow Corporation Information
4.8.2 Techdow Description, Business Overview
4.8.3 Techdow Low Molecular Weight Heparin Products Offered
4.8.4 Techdow Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Techdow Low Molecular Weight Heparin Sales by Product in 2021
4.8.6 Techdow Low Molecular Weight Heparin Sales by Application in 2021
4.8.7 Techdow Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.8.8 Techdow Recent Development
4.9 Yantai Dongcheng Pharmaceutical Group
4.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
4.9.2 Yantai Dongcheng Pharmaceutical Group Description, Business Overview
4.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Products Offered
4.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales by Product in 2021
4.9.6 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales by Application in 2021
4.9.7 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.9.8 Yantai Dongcheng Pharmaceutical Group Recent Development
5 Breakdown Data by Type
5.1 Global Low Molecular Weight Heparin Sales by Type (2017-2028)
5.1.1 Global Low Molecular Weight Heparin Sales by Type (2017-2022)
5.1.2 Global Low Molecular Weight Heparin Sales Forecast by Type (2023-2028)
5.1.3 Global Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
5.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2017-2028)
5.2.1 Global Low Molecular Weight Heparin Revenue by Type (2017-2022)
5.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2023-2028)
5.2.3 Global Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
5.3 Low Molecular Weight Heparin Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Low Molecular Weight Heparin Sales by Application (2017-2028)
6.1.1 Global Low Molecular Weight Heparin Sales by Application (2017-2022)
6.1.2 Global Low Molecular Weight Heparin Sales Forecast by Application (2023-2028)
6.1.3 Global Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
6.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2017-2028)
6.2.1 Global Low Molecular Weight Heparin Revenue by Application (2017-2022)
6.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2023-2028)
6.2.3 Global Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
6.3 Low Molecular Weight Heparin Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
7.2 North America Low Molecular Weight Heparin Market Facts & Figures by Country
7.2.1 North America Low Molecular Weight Heparin Sales by Country (2017-2028)
7.2.2 North America Low Molecular Weight Heparin Revenue by Country (2017-2028)
7.3 North America Low Molecular Weight Heparin Sales by Type
7.4 North America Low Molecular Weight Heparin Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Low Molecular Weight Heparin Market Facts & Figures by Region
8.2.1 Asia-Pacific Low Molecular Weight Heparin Sales by Region (2017-2028)
8.2.2 Asia-Pacific Low Molecular Weight Heparin Revenue by Region (2017-2028)
8.3 Asia-Pacific Low Molecular Weight Heparin Sales by Type
8.4 Asia-Pacific Low Molecular Weight Heparin Sales by Application
9 Europe
9.1 Europe Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
9.2 Europe Low Molecular Weight Heparin Market Facts & Figures by Country
9.2.1 Europe Low Molecular Weight Heparin Sales by Country (2017-2028)
9.2.2 Europe Low Molecular Weight Heparin Revenue by Country (2017-2028)
9.3 Europe Low Molecular Weight Heparin Sales by Type
9.4 Europe Low Molecular Weight Heparin Sales by Application
10 Latin America
10.1 Latin America Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
10.2 Latin America Low Molecular Weight Heparin Market Facts & Figures by Country
10.2.1 Latin America Low Molecular Weight Heparin Sales by Country (2017-2028)
10.2.2 Latin America Low Molecular Weight Heparin Revenue by Country (2017-2028)
10.3 Latin America Low Molecular Weight Heparin Sales by Type
10.4 Latin America Low Molecular Weight Heparin Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Low Molecular Weight Heparin Market Facts & Figures by Country
11.2.1 Middle East and Africa Low Molecular Weight Heparin Sales by Country (2017-2028)
11.2.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Country (2017-2028)
11.3 Middle East and Africa Low Molecular Weight Heparin Sales by Type
11.4 Middle East and Africa Low Molecular Weight Heparin Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Low Molecular Weight Heparin Supply Chain Analysis
12.2 Low Molecular Weight Heparin Key Raw Materials and Upstream Suppliers
12.3 Low Molecular Weight Heparin Clients Analysis
12.4 Low Molecular Weight Heparin Sales Channel and Sales Model Analysis
12.4.1 Low Molecular Weight Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Low Molecular Weight Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Low Molecular Weight Heparin Distributors
13 Market Dynamics
13.1 Low Molecular Weight Heparin Industry Trends
13.2 Low Molecular Weight Heparin Market Drivers
13.3 Low Molecular Weight Heparin Market Challenges
13.4 Low Molecular Weight Heparin Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Highlights
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Low Molecular Weight Heparin market is projected to reach US$ 491.4 million by 2028 from an estimated US$ 358.4 million in 2022, at a CAGR of 5.4% during 2023 and 2028.
Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 35%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Low Molecular Weight Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Low Molecular Weight Heparin.
The Low Molecular Weight Heparin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Low Molecular Weight Heparin market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low Molecular Weight Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Product Type Insights
Global markets are presented by Low Molecular Weight Heparin type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Low Molecular Weight Heparin are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Low Molecular Weight Heparin Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Low Molecular Weight Heparin market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Low Molecular Weight Heparin market.
Low Molecular Weight Heparin Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Low Molecular Weight Heparin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Low Molecular Weight Heparin industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Low Molecular Weight Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Low Molecular Weight Heparin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Market by Application
1.3.1 Global Low Molecular Weight Heparin Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Low Molecular Weight Heparin Market Size Estimates and Forecasts
2.1.1 Global Low Molecular Weight Heparin Revenue 2017-2028
2.1.2 Global Low Molecular Weight Heparin Sales 2017-2028
2.2 Low Molecular Weight Heparin Market Size by Region: 2022 Versus 2028
2.3 Low Molecular Weight Heparin Sales by Region (2017-2028)
2.3.1 Global Low Molecular Weight Heparin Sales by Region: 2017-2022
2.3.2 Global Low Molecular Weight Heparin Sales Forecast by Region (2023-2028)
2.3.3 Global Low Molecular Weight Heparin Sales Market Share by Region (2017-2028)
2.4 Low Molecular Weight Heparin Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Low Molecular Weight Heparin Revenue by Region: 2017-2022
2.4.2 Global Low Molecular Weight Heparin Revenue Forecast by Region (2023-2028)
2.4.3 Global Low Molecular Weight Heparin Revenue Market Share by Region (2017-2028)
3 Global Low Molecular Weight Heparin by Manufacturers
3.1 Global Top Low Molecular Weight Heparin Manufacturers by Sales
3.1.1 Global Low Molecular Weight Heparin Sales by Manufacturer (2017-2022)
3.1.2 Global Low Molecular Weight Heparin Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Low Molecular Weight Heparin Manufacturers by Revenue
3.2.1 Global Low Molecular Weight Heparin Revenue by Manufacturer (2017-2022)
3.2.2 Global Low Molecular Weight Heparin Revenue Share by Manufacturer (2017-2022)
3.3 Global Low Molecular Weight Heparin Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Low Molecular Weight Heparin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Low Molecular Weight Heparin Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Low Molecular Weight Heparin Manufacturing Base Distribution, Product Type
3.5.1 Low Molecular Weight Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Low Molecular Weight Heparin Product Type
3.5.3 Date of International Manufacturers Enter into Low Molecular Weight Heparin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Aspen
4.1.1 Aspen Corporation Information
4.1.2 Aspen Description, Business Overview
4.1.3 Aspen Low Molecular Weight Heparin Products Offered
4.1.4 Aspen Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Aspen Low Molecular Weight Heparin Sales by Product in 2021
4.1.6 Aspen Low Molecular Weight Heparin Sales by Application in 2021
4.1.7 Aspen Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.1.8 Aspen Recent Developments
4.2 Sanofi-aventis
4.2.1 Sanofi-aventis Corporation Information
4.2.2 Sanofi-aventis Description, Business Overview
4.2.3 Sanofi-aventis Low Molecular Weight Heparin Products Offered
4.2.4 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Sanofi-aventis Low Molecular Weight Heparin Sales by Product in 2021
4.2.6 Sanofi-aventis Low Molecular Weight Heparin Sales by Application in 2021
4.2.7 Sanofi-aventis Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.2.8 Sanofi-aventis Recent Developments
4.3 Pfizer
4.3.1 Pfizer Corporation Information
4.3.2 Pfizer Description, Business Overview
4.3.3 Pfizer Low Molecular Weight Heparin Products Offered
4.3.4 Pfizer Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Pfizer Low Molecular Weight Heparin Sales by Product in 2021
4.3.6 Pfizer Low Molecular Weight Heparin Sales by Application in 2021
4.3.7 Pfizer Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.3.8 Pfizer Recent Developments
4.4 Opocrin
4.4.1 Opocrin Corporation Information
4.4.2 Opocrin Description, Business Overview
4.4.3 Opocrin Low Molecular Weight Heparin Products Offered
4.4.4 Opocrin Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Opocrin Low Molecular Weight Heparin Sales by Product in 2021
4.4.6 Opocrin Low Molecular Weight Heparin Sales by Application in 2021
4.4.7 Opocrin Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.4.8 Opocrin Recent Developments
4.5 CSBIO
4.5.1 CSBIO Corporation Information
4.5.2 CSBIO Description, Business Overview
4.5.3 CSBIO Low Molecular Weight Heparin Products Offered
4.5.4 CSBIO Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.5.5 CSBIO Low Molecular Weight Heparin Sales by Product in 2021
4.5.6 CSBIO Low Molecular Weight Heparin Sales by Application in 2021
4.5.7 CSBIO Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.5.8 CSBIO Recent Developments
4.6 Dongying Tiandong Pharmaceutical
4.6.1 Dongying Tiandong Pharmaceutical Corporation Information
4.6.2 Dongying Tiandong Pharmaceutical Description, Business Overview
4.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Products Offered
4.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales by Product in 2021
4.6.6 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales by Application in 2021
4.6.7 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.6.8 Dongying Tiandong Pharmaceutical Recent Development
4.7 Changzhou Qianhong Bio-pharma
4.7.1 Changzhou Qianhong Bio-pharma Corporation Information
4.7.2 Changzhou Qianhong Bio-pharma Description, Business Overview
4.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Products Offered
4.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales by Product in 2021
4.7.6 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales by Application in 2021
4.7.7 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.7.8 Changzhou Qianhong Bio-pharma Recent Development
4.8 Techdow
4.8.1 Techdow Corporation Information
4.8.2 Techdow Description, Business Overview
4.8.3 Techdow Low Molecular Weight Heparin Products Offered
4.8.4 Techdow Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Techdow Low Molecular Weight Heparin Sales by Product in 2021
4.8.6 Techdow Low Molecular Weight Heparin Sales by Application in 2021
4.8.7 Techdow Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.8.8 Techdow Recent Development
4.9 Yantai Dongcheng Pharmaceutical Group
4.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
4.9.2 Yantai Dongcheng Pharmaceutical Group Description, Business Overview
4.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Products Offered
4.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales by Product in 2021
4.9.6 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales by Application in 2021
4.9.7 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales by Geographic Area in 2021
4.9.8 Yantai Dongcheng Pharmaceutical Group Recent Development
5 Breakdown Data by Type
5.1 Global Low Molecular Weight Heparin Sales by Type (2017-2028)
5.1.1 Global Low Molecular Weight Heparin Sales by Type (2017-2022)
5.1.2 Global Low Molecular Weight Heparin Sales Forecast by Type (2023-2028)
5.1.3 Global Low Molecular Weight Heparin Sales Market Share by Type (2017-2028)
5.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2017-2028)
5.2.1 Global Low Molecular Weight Heparin Revenue by Type (2017-2022)
5.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2023-2028)
5.2.3 Global Low Molecular Weight Heparin Revenue Market Share by Type (2017-2028)
5.3 Low Molecular Weight Heparin Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Low Molecular Weight Heparin Sales by Application (2017-2028)
6.1.1 Global Low Molecular Weight Heparin Sales by Application (2017-2022)
6.1.2 Global Low Molecular Weight Heparin Sales Forecast by Application (2023-2028)
6.1.3 Global Low Molecular Weight Heparin Sales Market Share by Application (2017-2028)
6.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2017-2028)
6.2.1 Global Low Molecular Weight Heparin Revenue by Application (2017-2022)
6.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2023-2028)
6.2.3 Global Low Molecular Weight Heparin Revenue Market Share by Application (2017-2028)
6.3 Low Molecular Weight Heparin Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
7.2 North America Low Molecular Weight Heparin Market Facts & Figures by Country
7.2.1 North America Low Molecular Weight Heparin Sales by Country (2017-2028)
7.2.2 North America Low Molecular Weight Heparin Revenue by Country (2017-2028)
7.3 North America Low Molecular Weight Heparin Sales by Type
7.4 North America Low Molecular Weight Heparin Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Low Molecular Weight Heparin Market Facts & Figures by Region
8.2.1 Asia-Pacific Low Molecular Weight Heparin Sales by Region (2017-2028)
8.2.2 Asia-Pacific Low Molecular Weight Heparin Revenue by Region (2017-2028)
8.3 Asia-Pacific Low Molecular Weight Heparin Sales by Type
8.4 Asia-Pacific Low Molecular Weight Heparin Sales by Application
9 Europe
9.1 Europe Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
9.2 Europe Low Molecular Weight Heparin Market Facts & Figures by Country
9.2.1 Europe Low Molecular Weight Heparin Sales by Country (2017-2028)
9.2.2 Europe Low Molecular Weight Heparin Revenue by Country (2017-2028)
9.3 Europe Low Molecular Weight Heparin Sales by Type
9.4 Europe Low Molecular Weight Heparin Sales by Application
10 Latin America
10.1 Latin America Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
10.2 Latin America Low Molecular Weight Heparin Market Facts & Figures by Country
10.2.1 Latin America Low Molecular Weight Heparin Sales by Country (2017-2028)
10.2.2 Latin America Low Molecular Weight Heparin Revenue by Country (2017-2028)
10.3 Latin America Low Molecular Weight Heparin Sales by Type
10.4 Latin America Low Molecular Weight Heparin Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Low Molecular Weight Heparin Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Low Molecular Weight Heparin Market Facts & Figures by Country
11.2.1 Middle East and Africa Low Molecular Weight Heparin Sales by Country (2017-2028)
11.2.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Country (2017-2028)
11.3 Middle East and Africa Low Molecular Weight Heparin Sales by Type
11.4 Middle East and Africa Low Molecular Weight Heparin Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Low Molecular Weight Heparin Supply Chain Analysis
12.2 Low Molecular Weight Heparin Key Raw Materials and Upstream Suppliers
12.3 Low Molecular Weight Heparin Clients Analysis
12.4 Low Molecular Weight Heparin Sales Channel and Sales Model Analysis
12.4.1 Low Molecular Weight Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Low Molecular Weight Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Low Molecular Weight Heparin Distributors
13 Market Dynamics
13.1 Low Molecular Weight Heparin Industry Trends
13.2 Low Molecular Weight Heparin Market Drivers
13.3 Low Molecular Weight Heparin Market Challenges
13.4 Low Molecular Weight Heparin Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(通信回線)の最新刊レポート

本レポートと同じKEY WORD(channel)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/05 10:26

153.43 円

167.28 円

201.52 円

ページTOPに戻る